Premium Nahrungsergänzungsmittel | artgerecht

L14 – ICD-10 Code: Bullous Skin Disorders

L14 is an ICD-10 diagnosis code for bullous skin disorders in diseases classified elsewhere. It describes blistering skin changes as a secondary manifestation of an underlying condition.

Regular tips about health Regular tips about health

Things worth knowing about "L14"

L14 is an ICD-10 diagnosis code for bullous skin disorders in diseases classified elsewhere. It describes blistering skin changes as a secondary manifestation of an underlying condition.

What Does ICD-10 Code L14 Mean?

The ICD-10 code L14 stands for Bullous disorders in diseases classified elsewhere. This diagnostic code is applied when blistering skin changes (bullae or vesicles) are not primarily caused by a standalone skin disease, but rather occur as a manifestation or complication of another underlying condition. The code belongs to the group of bullous disorders (L10–L14) within Chapter XII of the ICD-10 classification system, which covers diseases of the skin and subcutaneous tissue.

Causes and Underlying Conditions

Since L14 describes a secondary skin manifestation, the cause of blistering must always be traced back to an underlying disease. Common conditions associated with bullous skin changes include:

Autoimmune diseases: Systemic lupus erythematosus (SLE), rheumatoid arthritis, and other systemic conditions can cause skin manifestations involving blister formation.
Metabolic disorders: Diabetes mellitus can lead to spontaneous blister formation on the lower extremities, a condition known as bullosis diabeticorum.
Kidney disease: Chronic renal insufficiency may cause pseudoporphyria with bullous skin changes.
Infectious diseases: Certain infections can present with blistering skin symptoms as a secondary manifestation.
Porphyrias: Metabolic disorders of the haem biosynthesis pathway, classified under a different ICD code, but causing bullous skin symptoms.

Symptoms

The hallmark symptom of L14 is the formation of blisters (bullae) or small vesicles on the skin. These may vary in severity depending on the underlying condition:

Tension, redness, or inflammation around the blisters
Itching or burning in the affected skin area
Clear or turbid fluid inside the blisters
After rupture: raw wound surfaces, crust formation, or possible scarring
Preferential occurrence on mechanically stressed areas such as the feet or hands

Diagnosis

Diagnosing L14 requires a thorough clinical examination and investigation of the underlying cause. Common diagnostic steps include:

Skin biopsy: A small tissue sample is taken for histological and immunohistochemical analysis to characterize the type of blister formation.
Direct immunofluorescence: Detection of antibody or complement deposits in the skin to identify autoimmune causes.
Laboratory tests: Full blood count, kidney function tests, blood glucose, urinary porphyrins, and autoimmune antibodies (e.g., ANA, anti-dsDNA) to narrow down the underlying disease.
Clinical history: Documentation of medical history, comorbidities, and current medications.

Treatment

Since L14 represents a secondary skin manifestation, treatment of the underlying condition is the primary goal. In addition, symptomatic skin therapies are employed:

Treatment of the underlying disease: Optimizing diabetes management, treating autoimmune disease, managing renal conditions, etc.
Local wound care: Sterile drainage or careful opening of large blisters under hygienic conditions, followed by antiseptic wound treatment.
Topical corticosteroids: Corticosteroid-containing creams or ointments may be used for accompanying inflammatory reactions.
Avoidance of triggers: Protecting affected skin areas from mechanical pressure, UV radiation, or other precipitating factors.
Systemic therapy: In severe cases, systemic immunosuppressive treatment may be required, depending on the underlying disease.

Clinical Relevance of the ICD-10 Code

The ICD-10 code L14 is a so-called manifestation code. In clinical documentation, it should always be recorded together with the code for the underlying condition to fully represent the clinical picture. In medical coding practice, L14 is recorded as a secondary diagnosis alongside the primary underlying condition. This is essential for accurate billing and epidemiological recording of disease courses.

References

World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). WHO Press, Geneva. Available at: https://www.who.int/standards/classifications/classification-of-diseases
Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D (eds.): Rook's Textbook of Dermatology. 9th Edition. Wiley-Blackwell, Oxford, 2016. Chapter: Bullous Disorders.
James WD, Elston DM, Treat JR, Rosenbach MA: Andrews' Diseases of the Skin: Clinical Dermatology. 13th Edition. Elsevier, Philadelphia, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.